IRIS Institutional Research Information System - OPENBS Open Archive UniBS

GIACOMINI, ARIANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.566
EU - Europa 2.380
AS - Asia 2.198
SA - Sud America 449
AF - Africa 52
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 6
Totale 9.660
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.496
SG - Singapore 776
PL - Polonia 746
CN - Cina 677
IT - Italia 372
BR - Brasile 370
UA - Ucraina 309
DE - Germania 286
HK - Hong Kong 229
FI - Finlandia 187
VN - Vietnam 183
FR - Francia 95
GB - Regno Unito 90
TR - Turchia 79
RU - Federazione Russa 71
IE - Irlanda 67
IN - India 62
BD - Bangladesh 45
CA - Canada 35
SE - Svezia 35
AR - Argentina 29
ID - Indonesia 24
JP - Giappone 24
CZ - Repubblica Ceca 22
IQ - Iraq 22
NL - Olanda 22
MX - Messico 20
BE - Belgio 19
ZA - Sudafrica 18
ES - Italia 17
EC - Ecuador 14
AT - Austria 10
PK - Pakistan 9
SA - Arabia Saudita 9
UZ - Uzbekistan 8
VE - Venezuela 8
CH - Svizzera 7
MA - Marocco 7
NG - Nigeria 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
EU - Europa 6
PE - Perù 6
UY - Uruguay 6
AU - Australia 5
PY - Paraguay 5
TH - Thailandia 5
AZ - Azerbaigian 4
BG - Bulgaria 4
CO - Colombia 4
KE - Kenya 4
LT - Lituania 4
MY - Malesia 4
PH - Filippine 4
EG - Egitto 3
GR - Grecia 3
HR - Croazia 3
JM - Giamaica 3
JO - Giordania 3
KR - Corea 3
KZ - Kazakistan 3
LK - Sri Lanka 3
BH - Bahrain 2
BY - Bielorussia 2
CR - Costa Rica 2
CY - Cipro 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GD - Grenada 2
GE - Georgia 2
IL - Israele 2
NZ - Nuova Zelanda 2
PA - Panama 2
PT - Portogallo 2
AO - Angola 1
BO - Bolivia 1
DK - Danimarca 1
GA - Gabon 1
GT - Guatemala 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
KI - Kiribati 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
MG - Madagascar 1
MU - Mauritius 1
NO - Norvegia 1
NR - Nauru 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RO - Romania 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
Totale 9.659
Salva come PNG Salva come JPEG
Città #
Warsaw 741
Fairfield 542
Ashburn 477
Singapore 452
Woodbridge 334
Hong Kong 229
Jacksonville 221
Houston 218
Cambridge 214
Seattle 189
The Dalles 188
Wilmington 183
Chandler 170
Brescia 165
San Jose 163
Beijing 156
Ann Arbor 144
Helsinki 137
Princeton 116
New York 101
Los Angeles 93
Munich 78
Dearborn 76
Dublin 63
Lauterbourg 62
Istanbul 58
Ho Chi Minh City 53
Nanjing 51
Council Bluffs 44
São Paulo 43
Hanoi 37
Dong Ket 35
Chicago 34
Redondo Beach 34
Des Moines 33
Orem 32
San Francisco 31
Dallas 30
Shanghai 29
Milan 25
Nanchang 25
San Diego 25
Santa Clara 25
Buffalo 24
Moscow 22
Shenyang 21
Tokyo 21
London 19
Turku 19
Brussels 18
Jakarta 18
Jinan 18
Brno 17
Changsha 16
Phoenix 16
Denver 15
Boston 14
Chennai 14
Hebei 14
Rio de Janeiro 13
Verona 13
Amsterdam 12
Frankfurt am Main 12
Guangzhou 12
Montreal 12
Tianjin 12
Toronto 12
Johannesburg 11
Stockholm 11
Atlanta 10
Belo Horizonte 10
Dhaka 10
Jiaxing 10
Kocaeli 10
Lappeenranta 10
Baghdad 9
Boardman 9
Brooklyn 8
Charlotte 8
Da Nang 8
Falkenstein 8
Hefei 8
Lanzhou 8
Nuremberg 8
Tashkent 8
Haikou 7
Hangzhou 7
Ningbo 7
Porto Alegre 7
Tampa 7
Washington 7
Abuja 6
Campinas 6
Curitiba 6
Kunming 6
Lancaster 6
Parma 6
Roncadelle 6
Turin 6
Zurich 6
Totale 6.800
Salva come PNG Salva come JPEG
Nome #
Brain angioarchitecture and intussusceptive microvascular growth in a murine model of Krabbe disease 366
U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis 341
A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers 301
Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy. 299
Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors 281
Induction of death receptor 5 expression in tumor vasculature by perifosine restores the vascular disruption activity of TRAIL-expressing CD34(+) cells. 245
Long pentraxin-3 follows and modulates bladder cancer progression 218
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. 204
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells. 198
The Antitumor Didox Acts as an Iron Chelator in Hepatocellular Carcinoma Cells 193
The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis. 189
Long Pentraxin 3-Mediated Fibroblast Growth Factor Trapping Impairs Fibrosarcoma Growth 188
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy 183
Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation. 182
Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach 178
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 175
Myeloablative doses of yttrium-90-ibritumomab tiuxetan and the risk of secondary myelodysplasia/acute myelogenous leukemia 170
Circulating microRNAs and Their Role in Multiple Myeloma 167
Long pentraxin 3: A novel multifaceted player in cancer 167
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 158
Combining vascular disruption activity of TRAIL-expressing CD34+ cells with antiangiogenic activity of sorafenib improves regression of tumor growth 154
Future applications of FGF/FGFR inhibitors in cancer 152
Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy 148
Human CD34 + cells engineered to express membrane-bound tumor necrosis factor-related apoptosis-inducing ligand target both tumor cells and tumor vasculature 145
Inhibition of dna repair mechanisms and induction of apoptosis in triple negative breast cancer cells expressing the human herpesvirus 6 u94 144
The autocrine fgf/fgfr system in both skin and uveal melanoma: Fgf trapping as a possible therapeutic approach 142
A computational approach to compare microvessel distributions in tumors following antiangiogenic treatments 140
FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancer 137
Quantification of 3D Brain Microangioarchitectures in an Animal Model of Krabbe Disease 136
Uptake Profiles of Human Serum Exosomes by Murine and Human Tumor Cells through Combined Use of Colloidal Nanoplasmonics and Flow Cytofluorimetric Analysis 134
β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe Disease 134
(3)D [corrected] quantification of tumor vasculature in lymphoma xenografts in NOD/SCID mice allows to detect differences among vascular-targeted therapies 130
Sorafenib inhibits lymphoma xenografts by targeting MAPK/ERK and AKT pathways in tumor and vascular cells 130
sTRAIL coupled to liposomes improves its pharmacokinetic profile and overcomes neuroblastoma tumour resistance in combination with Bortezomib 130
Discovery of novel FGF trap small molecules endowed with anti-myeloma activity 128
FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation-Induced Mitochondrial Oxidative Stress 128
Perifosine and sorafenib combination induces mitochondrial cell death and antitumor effects in NOD/SCID mice with Hodgkin lymphoma cell line xenografts 127
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors 125
Cannabidiol alters mitochondrial bioenergetics via VDAC1 and triggers cell death in hormone-refractory prostate cancer 119
Halting the FGF/FGFR axis leads to anti-tumor activity in Waldenström's Macroglobulinemia by silencing MYD88 119
Targeting the Endothelin-1 Receptors Curtails Tumor Growth and Angiogenesis in Multiple Myeloma 118
Stromal expression of long Pentraxin-3 impairs tumor growth and metastasis 114
Vascular amounts and dispersion of caliber-classified vessels as key parameters to quantitate 3D micro-angioarchitectures in multiple myeloma experimental tumors 112
Chemical modification of NSC12 leads to a specific FGF-trap with antitumor activity in multiple myeloma 109
Potent in vivo anti-tumor activity of extracellular vesicles isolated from genetically engineered primary mesenchymal stromal cells expressing the trans-membrane TNF-Related Apoptosis-Inducing Ligand (TRAIL) 108
Surveillance of spontaneous breast cancer metastasis by TRAIL-expressing CD34⁺ cells in a xenograft model 108
Pentraxin 3 inhibits the angiogenic potential of multiple myeloma cells 106
PTX3 Modulates Neovascularization and Immune Inflammatory Infiltrate in a Murine Model of Fibrosarcoma 105
Glyco-Coated CdSe/ZnS Quantum Dots as Nanoprobes for Carbonic Anhydrase IX Imaging in Cancer Cells 103
Modeling Acquired Resistance to the Second-Generation Androgen Receptor Antagonist Enzalutamide in the TRAMP Model of Prostate Cancer 102
The PTX3/TLR4 autocrine loop as a novel therapeutic target in triple negative breast cancer 101
Inhibition of the FGF/FGFR System Induces Apoptosis in Lung Cancer Cells via c-Myc Downregulation and Oxidative Stress 100
Iron supplementation enhances RSL3-induced ferroptosis to treat naïve and prevent castration-resistant prostate cancer 99
β-Galactosylceramidase Promotes Melanoma Growth via Modulation of Ceramide Metabolism 95
Design, synthesis, in vitro and in vivo biological evaluation of 2-amino-3-aroylbenzo[b]furan derivatives as highly potent tubulin polymerization inhibitors 91
The FGF/FGFR System in the Physiopathology of the Prostate Gland 91
The FGF/FGFR/c-Myc axis as a promising therapeutic target in multiple myeloma 89
Specific targeting of the KRAS mutational landscape in myeloma as a tool to unveil the elicited anti-tumor activity 89
FGF-trapping hampers cancer stem-like cells in uveal melanoma 83
Human CD34+ Cells Expressing Membrane-Bound Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Exert a Potent Anti-Lymphoma Effects by Targeting Tumor Vasculature 81
Post-transplant evaluation of bone marrow hematopoietic function in patients receiving high-dose Yttrium-90-Ibritumomab Tiuxetan (Zevalin) with autograft 75
The natural FGF-trap long pentraxin 3 inhibits lymphangiogenesis and lymphatic dissemination 72
Targeting TRAIL Receptors with Genetically-Engineered CD34+ Hematopoietic Stem Cells 72
The Risk of Secondary Myelodysplastic Syndrome/Acute Leukemia Following High-Dose Yttrium-90 Ibritumomab Tiuxetan Is Analogous to That Observed Following High-Dose Chemotherapy: a Matched-Pair Analysis In Non-Hodgkin Lymphoma Patients 70
Turn-Adopting Peptidomimetic as a Formyl Peptide Receptor-1 Antagonist 68
Proteasome inhibitors as anticancer agents 66
Preclinical Rationale for the Use of the Multikinase Inhibitor Sorafenib in the Treatment of Human Lymphomas 65
The histone deacetylase inhibitor ITF2357 (Givinostat) promotes Burkitt’s lymphoma cell line death modulating micro-RNA and Tissue Transglutaminase 2 expression 63
Preclinical Rationale for the Use of the Combined Treatment with the AKT Inhibitor Perifosine and the Multikinase Inhibitor Sorafenib in Hodgkin Lymphoma 60
Monoclonal antibodies for targeted treatment of lymphoproliferative neoplasias 44
An ureido-substituted benzenesulfonamide carbonic anhydrase inhibitor exerts a potent antitumor effect in vitro and in vivo 39
FGF/FGFR inhibitors downmodulates c-Myc oncoprotein and hampers the growth of adrenocortical carcinoma 35
Totale 9.838
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.309
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.309
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021355 0 0 0 0 0 0 0 0 0 161 102 92
2021/2022593 38 79 29 21 20 40 38 42 16 74 46 150
2022/2023497 80 15 29 29 43 120 6 51 68 1 37 18
2023/2024615 42 13 96 27 20 101 22 26 125 24 17 102
2024/20251.351 21 23 14 198 131 140 118 81 146 88 229 162
2025/20262.821 303 369 202 421 344 230 458 120 160 214 0 0
Totale 9.838